ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,203,256 | -7.0% | 39,143 | +9.0% | 0.01% | -28.6% |
| Q1 2023 | $1,294,270 | +182.8% | 35,922 | +210.2% | 0.01% | +250.0% |
| Q4 2022 | $457,721 | -76.5% | 11,582 | -76.1% | 0.00% | -77.8% |
| Q3 2022 | $1,950,000 | +8025.0% | 48,525 | +8266.4% | 0.01% | – |
| Q2 2022 | $24,000 | -89.3% | 580 | -89.9% | 0.00% | -100.0% |
| Q1 2022 | $224,000 | +622.6% | 5,759 | +644.1% | 0.00% | – |
| Q4 2021 | $31,000 | -99.4% | 774 | -99.4% | 0.00% | -100.0% |
| Q3 2021 | $4,881,000 | -57.7% | 135,049 | -52.1% | 0.01% | -52.0% |
| Q2 2021 | $11,550,000 | +5247.2% | 281,774 | +5598.2% | 0.02% | +2400.0% |
| Q1 2021 | $216,000 | -77.8% | 4,945 | -75.3% | 0.00% | -87.5% |
| Q2 2020 | $971,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |